http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112067810-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6084941b94f1d7a9788e9a5b73026490 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5762 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5764 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 |
| filingDate | 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a43d23ddd6ceb8bb2482df25a2b08885 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b362d90c4a29a764eba05f63731b0506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_637c6382ea015e6d0420abaea14ec581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b38fe8473cda6a4584ee5088d0719a95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d7dfdff992e6d8cf452ba054b055ec1 |
| publicationDate | 2020-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112067810-A |
| titleOfInvention | Infectious disease marker compound quality control product, detection reagent and detection kit |
| abstract | The invention relates to the field of biological testing, in particular to an infectious disease marker composite quality control product, a detection reagent and a detection kit. The quality control product of the invention has a high degree of compounding, selects a protein buffer as a matrix, and all raw and auxiliary materials used in the preparation process have been inactivated, thereby eliminating the harm of various potential pathogenic microorganisms. At the same time, the quality control product is designed and applicable to the mainstream manufacturers' instruments on the market, and has a wide range of applications, which can meet the detection needs of infectious disease markers in the market. The quality control product can not only be used for the quality control of the five infectious disease markers detection process at the same time, and provide an accurate basis for the diagnosis of clinical diseases; but also has good uniformity and stability, which not only facilitates clinical operations and reduces the possibility of operational errors It also saves costs and provides a reliable guarantee for the accuracy of clinical test results. |
| priorityDate | 2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.